Anavex Life Sciences Corp (AVXL)

[ckent]

Went back and searched through the archives for mention of a wash out period and this was the only one I found from 2015. Doesn't mean there aren't others that I missed but based on my quick scan this is what I found.

Anavex Announces Positive Primary and Secondary Endpoints were Achieved in a Phase 2a Clinical Trial

" Even though PART A was designed as a 5 week bioavailability trial that included a built-in wash-out period of 12 days and without an optimized dosing regimen, several Cogstate tests demonstrated highly statistically significant improvements. This finding was supported by a trend towards improvement in median MMSE score, which increased by +1.5 over baseline at week 5.
Positive effects on cognition were further supported by highly statistically significant biomarker effects of treatment at week 5 on one event-related potential (ERP) measure with a p-value of p<0.0007 and improvement in the P300 signal. The ERP biomarker scores improved compared to the initial data presented at AAIC in Washington, DC in July 2015, by which time not all patients had yet completed PART A."

For anyone who missed it, this was about a peer-reviewed publication from Neuropharmacology last year titled, “Future avenues for Alzheimer’s disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery” from the series of the special issue on ’The Quest for Disease-Modifying Therapies for Neurodegenerative Disorders’. It includes a comparison to Aducanumab, Aricept and Memantine.

Anavex Life Sciences Reports ANAVEX®2-73 featured as a Disease-Modifying Small Molecule in Trials